#Synbiotec

5stories

21 Declast updated

Buy-And-Build Cannabis Company Pivots to Adult-Use Opportunities In Its Domestic Market

GERMAN firm SynBiotic has just completed what it calls the ‘most significant merger in the European cannabis sector’ to date, as it considers how best to position itself to capitalise on the incoming recreational opportunity.

Ben Stevens21 December 2021

Hemp Industry

SynBiotic SE Buys Hemp Pioneer’s Group Of Companies For €11.2m

1 December 2021

Medical

Cannabis Company’s Buy And Build Strategy Boosted By High Profile Investor Support

8 November 2021

Press releases

German Cannabis Company Continues Its Strong Growth – A Further Seven Million Euros For SynBiotic SE

27 October 2021

More in #Synbiotec

Press releases
German Cannabis Company SynBiotic SE Plans Canadian Cross-Listing
CANNABIS company SynBiotic SE, already listed on the Frankfurt and Düsseldorf stock exchanges, is now to be listed on the Canadian NEO Exchange in Toronto – a new FinTech stock exchange that has been revolutionizing the market since 2014, offering modern services across the capital market.
BusinessCann13 Oct

Sections

Data & Trackers

What’s On

More